Table 8.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1997 to 2006

Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Functioning Graft at Discharge 823 933 907 888 862 880 847 863 885 905
With Immunosuppression Info 823 933 907 886 861 880 844 849 880 867
Corticosteroids Any in Category 97.8% 97.5% 97.9% 97.1% 93.3% 89.5% 83.8% 75.1% 71.0% 66.8%
Prednisone 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Steroids 97.8% 97.5% 97.9% 97.0% 93.3% 89.5% 83.8% 75.1% 71.0% 66.8%
Cyclosporine Any in Category 47.5% 31.4% 23.3% 18.8% 13.7% 9.8% 8.9% 6.2% 6.7% 6.2%
Sandimmmune 6.3% 3.2% 2.4% 1.9% 0.9% 0.8% 0.1% 0.1% 0.2% 0.2%
Neoral 41.2% 28.2% 20.7% 16.1% 10.8% 6.8% 7.2% 5.3% 5.2% 5.2%
Gengraf 0.0% 0.0% 0.1% 0.8% 2.0% 1.9% 1.5% 0.8% 1.3% 0.8%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 56.7% 69.6% 75.3% 82.3% 86.6% 90.3% 83.9% 84.6% 88.9% 92.4%
Tacrolimus 56.7% 69.6% 75.3% 82.3% 86.6% 90.3% 83.9% 84.6% 88.9% 92.4%
Antimetabolites Any in Category 94.2% 94.9% 92.7% 84.9% 79.9% 82.0% 82.7% 83.6% 81.7% 85.0%
Mycophenolate Mofetil 84.4% 87.0% 89.4% 82.4% 78.9% 81.0% 81.6% 81.7% 74.5% 72.4%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.5% 6.9% 11.4%
Azathioprine 9.6% 7.8% 3.3% 2.5% 1.0% 1.0% 1.1% 0.4% 0.2% 1.2%
Cytoxan 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.1% 0.5% 1.2% 13.2% 21.4% 19.0% 19.3% 16.8% 15.3% 16.3%
Sirolimus 0.1% 0.5% 1.0% 13.0% 21.4% 19.0% 19.2% 16.8% 15.3% 16.3%
Everolimus 0.0% 0.0% 0.2% 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.